Hypoxia-induced factor and its role in liver fibrosis
- PMID: 36523459
- PMCID: PMC9745792
- DOI: 10.7717/peerj.14299
Hypoxia-induced factor and its role in liver fibrosis
Abstract
Liver fibrosis develops as a result of severe liver damage and is considered a major clinical concern throughout the world. Many factors are crucial for liver fibrosis progression. While advancements have been made to understand this disease, no effective pharmacological drug and treatment strategies have been established that can effectively prevent liver fibrosis or even could halt the fibrotic process. Most of those advances in curing liver fibrosis have been aimed towards mitigating the causes of fibrosis, including the development of potent antivirals to inhibit the hepatitis virus. It is not practicable for many individuals; however, a liver transplant becomes the only suitable alternative. A liver transplant is an expensive procedure. Thus, there is a significant need to identify potential targets of liver fibrosis and the development of such agents that can effectively treat or reverse liver fibrosis by targeting them. Researchers have identified hypoxia-inducible factors (HIFs) in the last 16 years as important transcription factors driving several facets of liver fibrosis, making them possible therapeutic targets. The latest knowledge on HIFs and their possible role in liver fibrosis, along with the cell-specific activities of such transcription factors that how they play role in liver fibrosis progression, is discussed in this review.
Keywords: Alcoholic fatty liver disease; Fatty liver diseases; Hepatocellular carcinoma; Hyoxia-induced factors; Hyptocytes; Kapffur cells; Liver cirrhosis; Liver fibrosis; Macrophages; Stellate cells.
©2022 Mohammad Omar et al.
Conflict of interest statement
The authors declare there are no competing interests.
Figures
Similar articles
-
Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis.Cells. 2021 Jul 13;10(7):1764. doi: 10.3390/cells10071764. Cells. 2021. PMID: 34359934 Free PMC article. Review.
-
Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis.Cell Mol Gastroenterol Hepatol. 2015 Sep 25;1(6):589-597. doi: 10.1016/j.jcmgh.2015.09.005. eCollection 2015 Nov. Cell Mol Gastroenterol Hepatol. 2015. PMID: 28210703 Free PMC article. Review.
-
Pathophysiology of Liver Fibrosis.Dig Dis. 2015;33(4):492-7. doi: 10.1159/000374096. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159264
-
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.Histol Histopathol. 2014 Jan;29(1):33-44. doi: 10.14670/HH-29.33. Epub 2013 Sep 2. Histol Histopathol. 2014. PMID: 23996844 Review.
-
Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.J Pharmacol Exp Ther. 2012 May;341(2):307-16. doi: 10.1124/jpet.111.189340. Epub 2012 Jan 23. J Pharmacol Exp Ther. 2012. PMID: 22271822 Free PMC article.
Cited by
-
Probing Liver Injuries Induced by Thioacetamide in Human In Vitro Pooled Hepatocyte Experiments.Int J Mol Sci. 2024 Mar 13;25(6):3265. doi: 10.3390/ijms25063265. Int J Mol Sci. 2024. PMID: 38542239 Free PMC article.
-
Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies.Front Pharmacol. 2023 Jul 27;14:1243675. doi: 10.3389/fphar.2023.1243675. eCollection 2023. Front Pharmacol. 2023. PMID: 37576819 Free PMC article. Review.
-
Tumor heterogeneity: preclinical models, emerging technologies, and future applications.Front Oncol. 2023 Apr 28;13:1164535. doi: 10.3389/fonc.2023.1164535. eCollection 2023. Front Oncol. 2023. PMID: 37188201 Free PMC article. Review.
References
-
- Abbas N, Getachew A, You K, Shah Z, Chen Y, Tao J, Hussain M, Yang F, Zhuang Y, Xu Y, Li Y-X. Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage. Biochemical and Biophysical Research Communications. 2020;529:474–479. doi: 10.1016/j.bbrc.2020.06.041. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical